Invited commentary on “Thyrotropin Suppression therapy Using Levothyroxine Does Not Negatively Affect Breast Cancer Prognosis”
Main Author: | J.N. Kolla |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294222000570 |
Similar Items
-
Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine
by: Karol Kaziród-Wolski, et al.
Published: (2021-11-01) -
Weekly Versus Daily Levothyroxine Tablet Replacement in Adults with Hypothyroidism
by: Harold Henrison Chiu, et al.
Published: (2022-07-01) -
CONTEMPORARY APPROACHES TO LEVOTHYROXINE THERAPY AFTER SURGERY IN PATIENTS WITH WELL-DIFFERENTIATED THYROID CANCER
by: P. O. Rumyantsev, et al.
Published: (2015-04-01) -
Analysis of factors influencing the dose of levothyroxine treatment in adequately controlled hypothyroid patients of different etiologies
by: Márk Stempler, et al.
Published: (2024-10-01) -
Tea consumption affects the absorption of levothyroxine
by: Ying-Wen Lai, et al.
Published: (2022-09-01)